Latest Clinical Data on Namenda for Alzheimer’s Patients Confirms Beneficial Effects

Latest Clinical Data on Namenda for Alzheimer’s Patients Confirms Beneficial Effects
Results from four recent studies confirmed the beneficial clinical effects of Namenda (memantine), an FDA-approved Alzheimer’s therapy, to treat the disease’s behavioral and functional symptoms in people with moderate to severe disease. The studies, sponsored by Allergan, are being presented in poster format at the 2017 annual meeting of the American Academy of Neurology (AAN), taking place through April 28

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

5 comments

  1. Arne Brun says:

    Always grateful for your communications. Much of it eludes me now however since it is printed in weak colours, a common misstake by designers! I like many others with macular degeneration can not read such text, so please make it black against white. also please change my mailadress as below.

Leave a Comment

Your email address will not be published. Required fields are marked *